INTECH Investment Management’s Dyne Therapeutics DYN Stock Holding History

INTECH Investment Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$656K	Sell	29,553 -47	-0.2%	-$874	0.01%	1217
2026 Q1	$537K	Sell	29,600 -14,688	-33%	-$253K	0.01%	1305
2025 Q4	$866K	Sell	44,288 -8,762	-17%	-$166K	0.01%	1209
2025 Q3	$671K	Sell	53,050 -12,976	-20%	-$148K	0.01%	1409
2025 Q2	$629K	Sell	66,026 -11,325	-15%	-$125K	0.01%	1468
2025 Q1	$809K	Buy	77,351 +43,375	+128%	+$620K	0.01%	1330
2024 Q4	$800K	Buy	33,976 +8,162	+32%	+$241K	0.01%	1286
2024 Q3	$927K	Buy	+25,814	New	+$1.03M	0.01%	858

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

INTECH Investment Management's DYN Position: Q2 2026 in Review

INTECH Investment Management reduced its Dyne Therapeutics (DYN) stake by 0.16% in Q2 2026, selling an estimated $874 and leaving 29,553 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #1217.

INTECH Investment Management first reported a position in DYN in Q3 2024 and has held it in 8 quarters since. The position peaked at $927K in Q3 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

INTECH Investment Management held 29,553 shares of Dyne Therapeutics worth $656K as of Q2 2026.
INTECH Investment Management sold 47 Dyne Therapeutics shares in Q2 2026, an estimated $874.
Dyne Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1217 holding.
INTECH Investment Management first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Dyne Therapeutics position peaked at $927K in Q3 2024.
245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.